TAKAO MASAKI

Last Updated :2024/05/07

Affiliations, Positions
Hiroshima University Hospital, Professor
E-mail
masakithiroshima-u.ac.jp
Self-introduction
My speciality is Nephrology.

Basic Information

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Kidney internal medicine

Affiliated Academic Societies

  • The Japanese Society of Internal Medicine Japanese Society of Nephrology The Japanese Society for Dialysis Therapy The Japanese Association of Rehabilitation Medicine Japanese Society for Peritoneal Dialysis Japanese Society for Hemodiafiltration American Society of Nephrology International Society of Nephrology European Renal Association

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2024, Undergraduate Education, Intensive, Practice for medical research
  3. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2024, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2024, Graduate Education (Master's Program) , 1Term, Advanced Lecture on Preventive Medicine for Evidence-based Health Guidance A
  6. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Nephrology
  7. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Nephrology
  8. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Nephrology
  9. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Nephrology

Research Activities

Academic Papers

  1. Cumulative Dialytic Glucose Exposure is a Risk Factor for Peritoneal Fibrosis and Angiogenesis in Pediatric Patients Undergoing Peritoneal Dialysis Using Neutral-pH Fluids, Kidney Int Rep, 7(11), 2431-2445, 20220903
  2. Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study, PLoS One, 17(11), 20221129
  3. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients, Am J Nephrol ., 53(2-3), 169-175, 2022
  4. Nephrotic-range proteinuria and membranoproliferative glomerulonephritis-like pattern caused by interferon-beta1b in a patient with multiple sclerosis, CEN Case Rep, 202212
  5. Klotho protects chromosomal DNA from radiation-induced damage, JOURNAL OF BIOCHEMISTRY, 173(5), 375-382, 20230426
  6. Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 27(5), 419-426, 202305
  7. alpha 1-and beta 2-Microglobulin reduction ratios and survival in patients on predilution online haemodiafiltration, NEPHROLOGY, 28(1), 44-50, 202301
  8. A case report of atypical anti-glomerular basement membrane disease, BMC NEPHROLOGY, 23(1), 20221119
  9. The hypoxia-inducible factor-alpha prolyl hydroxylase inhibitor FG4592 ameliorates renal fibrosis by inducing the H3K9 demethylase JMJD1A, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 323(5), F539-F552, 202211
  10. N-terminal pro-brain natriuretic peptide predicts hospitalization for ischemic stroke in Japanese hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 26(11), 1111-1118, 202211
  11. Relationships of hyperchloremia with hypertension and proteinuria in patients with chronic kidney disease, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 26(9), 880-885, 202209
  12. Penile calciphylaxis in patients with end-stage kidney disease undergoing dialysis: Invasive treatment and pain management, THERAPEUTIC APHERESIS AND DIALYSIS, 26(5), 950-959, 202210
  13. Coronary artery calcification is a risk factor for intradialytic hypotension in patients undergoing hemodialysis, HEMODIALYSIS INTERNATIONAL, 26(3), 335-344, 202207
  14. Upregulation of Mineralocorticoid Receptor Contributes to Development of Salt-Sensitive Hypertension after Ischemia-Reperfusion Injury in Rats, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(14), 7831-7831, 202207
  15. Synergistic Effects of the Geriatric Nutritional Risk Index and the Modified Creatinine Index for Predicting Mortality in Patients on Hemodialysis, NUTRIENTS, 14(12), 2398-2398, 202206
  16. Convection volume, beta 2-microglobulin and alpha 1-microglobulin reduction ratios, and body composition in pre-dilution online haemodiafiltration, NEPHROLOGY, 27(7), 601-609, 202207
  17. A Combination of Iohexol Treatment and Ionizing Radiation Exposure Enhances Kidney Injury in Contrast-Induced Nephropathy by Increasing DNA Damage, RADIATION RESEARCH, 197(4), 384-395, 202204
  18. COVID-19-associated pulmonary aspergillosis in hemodialysis patients, CLINICAL KIDNEY JOURNAL, 15(5), 985-991, 20220429
  19. 15-Deoxy-Delta 12,14-prostaglandin J(2) Inhibits Angiotensin II-induced Fibronectin Expression via Hepatocyte Growth Factor Induction in Human Peritoneal Mesothelial Cells, THERAPEUTIC APHERESIS AND DIALYSIS, 14(1), 43-51, 201002
  20. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta 1 signaling, KIDNEY INTERNATIONAL, 84(2), 297-307, 201308
  21. PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation., Clin Exp Immunol, 144(2), 353-361, 20060501
  22. Factors influencing arteriovenous fistula dysfunction in Japanese patients on chronic hemodialysis, The International Journal of Artificial Organs, 22(1), 14-17, 19990401
  23. ★, Tenascin expression may reflect the activity and chronicity of human IgA nephropathy., 50(4), 205-213, 19981001
  24. Role of tenascin in human immunoglobulin A nephropathy., 25(5), 247-254, 19970901
  25. The influence of steroid therapy in patients with IgA nephropathy., Nephron, 86(6), 197-198, 20001001
  26. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney., Kidney International, 63(4), 1256-1264, 20030401
  27. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis., Nephrology Dialysis Transplantation, 18(1), 178-181, 20030101
  28. Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies., Journal of the American Society of Nephrology, 15(7), 1835-1843, 20040601
  29. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis., Clin Exp Nephrol, 20130701
  30. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6), 921-929, 201212
  31. Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats, PLOS ONE, 9(4), 20140402
  32. Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(2), 189-193, 201404
  33. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(3), 499-506, 201406
  34. Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(12), 2117-2122, 201412
  35. Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome, CLINICAL NEPHROLOGY, 82(4), 268-272, 201410
  36. The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, INTERNAL MEDICINE, 54(8), 887-894, 2015
  37. Hemodialysis Immediately After Cardiac Catheterization Is a Risk Factor for Intradialytic Hypotension, THERAPEUTIC APHERESIS AND DIALYSIS, 19(3), 245-249, 201506
  38. Expression of age-related factors during the development of renal damage in patients with IgA nephropathy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(5), 830-837, 201510
  39. Vascular access intervention by a nephrologist in Hiroshima, JOURNAL OF VASCULAR ACCESS, 16, S58-S61, 201511
  40. Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model., Nephron Exp Nephrol, 112(2), 59-69, 2009
  41. Effect of AST-120, an oral adsorbrnt, on inhibition of the loss of renal function in CRF patients, NEPHROLOGY DIALYSIS TRANSPLANTATION, 21, 383-383, 2006
  42. Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2, THERAPEUTIC APHERESIS AND DIALYSIS, 11(2), 94-100, 2007
  43. Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction, NEPHROLOGY, 12(6), 565-571, 2007
  44. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury, TRANSPLANTATION, 84(2), 207-213, 2007
  45. Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice., PLoS One., 11(8), e0160993, 20160811
  46. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study., Hemodial Int, 20(4), 580-588, 201610
  47. Linagliptin Ameliorates MethylglyoxalInduced Peritoneal Fibrosis in Mice, PLOS ONE, 11(8), 20160811
  48. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study, HEMODIALYSIS INTERNATIONAL, 20(4), 580-588, 201610
  49. Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study, JOURNAL OF VIRAL HEPATITIS, 23(11), 850-856, 201611
  50. Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(6), 918-925, 201612
  51. Seasonal variation in hemodialysis initiation: A single-center retrospective analysis, PLOS ONE, 12(5), 20170602
  52. AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations, CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 7(2), 102-107, 2017
  53. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients, THERAPEUTIC APHERESIS AND DIALYSIS, 12(3), 232-236, 2008
  54. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis, NEPHROLOGY DIALYSIS TRANSPLANTATION, 23(11), 3418-3426, 2008
  55. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta, LABORATORY INVESTIGATION, 89(1), 47-58, 2009
  56. Mizoribine Suppresses the Progression of Experimental Peritoneal Fibrosis in a Rat Model, NEPHRON EXPERIMENTAL NEPHROLOGY, 112(2), E59-E69, 2009
  57. C-C Chemokine Receptor 2 Expression by Circulating Monocytes Influences Atherosclerosis in Patients on Chronic Hemodialysis, THERAPEUTIC APHERESIS AND DIALYSIS, 13(3), 205-212, 2009
  58. 15-Deoxy-Delta 12,14-prostaglandin J(2) Inhibits Angiotensin II-induced Fibronectin Expression via Hepatocyte Growth Factor Induction in Human Peritoneal Mesothelial Cells, THERAPEUTIC APHERESIS AND DIALYSIS, 14(1), 43-51, 2010
  59. A SUPER HIGH-FLUX DIALYZER (PS: APS-EA) ELIMINATES 40% OF INJECTED RECOMBINANT HUMAN (RH) ERITHROPOIETIN (EPO) DURING 4-HOUR HEMODIALYSIS (HD), NEPHROLOGY DIALYSIS TRANSPLANTATION, 27, 213-213, 2012
  60. PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) HETERODIMERS REDUCE SERUM LDL-CHOLESTEROL (LDL-C) LEVELS IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS ASSOCIATED WITH DYSLIPIDEMIA CHARACTERIZED BY INCREASED TRIGLYCERIDE-RICH LIPOPROTEINS, NEPHROLOGY DIALYSIS TRANSPLANTATION, 27, 215-216, 2012
  61. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6), 921-929, 2012
  62. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta 1 signaling, KIDNEY INTERNATIONAL, 84(2), 297-307, 2013
  63. Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats, PLOS ONE, 9(4), 2014
  64. Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(2), 189-193, 2014
  65. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(3), 499-506, 2014
  66. Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(12), 2117-2122, 2014
  67. Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome, CLINICAL NEPHROLOGY, 82(4), 268-272, 2014
  68. The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, INTERNAL MEDICINE, 54(8), 887-894, 2015
  69. Hemodialysis Immediately After Cardiac Catheterization Is a Risk Factor for Intradialytic Hypotension, THERAPEUTIC APHERESIS AND DIALYSIS, 19(3), 245-249, 2015
  70. Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(4), 631-638, 2015
  71. Expression of age-related factors during the development of renal damage in patients with IgA nephropathy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(5), 830-837, 2015
  72. Vascular access intervention by a nephrologist in Hiroshima, JOURNAL OF VASCULAR ACCESS, 16, S58-S61, 2015
  73. Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 27(1), 203-215, 2016
  74. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression, KIDNEY INTERNATIONAL, 89(1), 147-157, 2016
  75. High glucose promotes TGF-beta 1 production by inducing FOS expression in human peritoneal mesothelial cells, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(1), 30-38, 2016
  76. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis., Clin Exp Nephrol, 2017
  77. Valproic acid attenuates renal fibrosis through the induction of autophagy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 21(5), 771-780, 201710
  78. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients, NEPHROLOGY, 22(12), 947-953, 201712
  79. Diffuse large B-cell lymphoma presenting as bilateral renal infiltration leading to acute kidney injury, CEN CASE REPORTS, 6(2), 140-147, 201711
  80. Protective Effects of Japanese Soybean Paste (Miso) on Stroke in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP), AMERICAN JOURNAL OF HYPERTENSION, 31(1), 43-47, 201801
  81. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 78-84, 201802
  82. Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS, 22(1), 31-39, 201802
  83. A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-alpha and TGF-beta(1) pathways, SCIENTIFIC REPORTS, 7, 20170515
  84. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients, INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 41(3), 135-143, 201803
  85. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report, BMC NEPHROLOGY, 19, 20180503
  86. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, PLOS ONE, 13(5), 20180503
  87. A case of immunotactoid glomerulopathy with false-negative IgG staining, BMC NEPHROLOGY, 19, 20180615
  88. High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 835-842, 201808
  89. Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II, CELL DEATH & DISEASE, 9(808), 20180724
  90. Klotho as a Therapeutic Target during the Development of Renal Fibrosis, SCIENTIFIC ASPECTS OF DIALYSIS THERAPY: JSDT/ISBP ANNIVERSARY EDITION, 189, 178-183, 2017
  91. Na+-Cl- cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused rats, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 315(2), 300-312, 2018
  92. Dec1 and CLOCK Regulate Na+/K+-ATPase 1 Subunit Expression and Blood Pressure, HYPERTENSION, 72(3), 746-754, 201809
  93. A Case of Fibronectin Glomerulopathy Caused by Missense Mutations in the Fibronectin 1 Gene, kidney Int Rep, 2(5), 969-972, 2017
  94. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, Nephrology (Carlton), 23(9), 837-845, 2018
  95. AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations., Case Rep Nephrol Dial, 7, 102-107, 2017
  96. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, NEPHROLOGY, 23(9), 837-845, 201809
  97. Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction, PLOS ONE, 13(8), 20180816
  98. Comparing the 12-month patency of low- versus high-pressure dilation in failing arteriovenous fistulae: A prospective multicenter trial (YOROI study), JOURNAL OF VASCULAR ACCESS, 19(5), 477-483, 201809
  99. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(5), 1167-1173, 201810
  100. TGF-beta 1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRA, SCIENTIFIC REPORTS, 8, 20180919
  101. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis, STEM CELLS TRANSLATIONAL MEDICINE, 7(12), 893-905, 201812
  102. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells, JOURNAL OF BIOLOGICAL CHEMISTRY, 294(1), 101-115, 20190104
  103. The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19(12), 201812
  104. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report, CLINICAL NEPHROLOGY, 90(3), 232-236, 201809
  105. Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan, JOURNAL OF ARTIFICIAL ORGANS, 22(2), 146-153, 201906
  106. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis, PLOS ONE, 12(3), 20170309
  107. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients, INTERNATIONAL UROLOGY AND NEPHROLOGY, 51(6), 1043-1052, 201906
  108. Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(1), 217-223, 20190618
  109. Renal medullary tonicity regulates RNF183 expression in the collecting ducts via NFAT5, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(2), 436-442, 20190625
  110. microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress, PLOS ONE, 14(6), 20190614
  111. Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice, DIABETOLOGY & METABOLIC SYNDROME, 11, 20190722
  112. Novel Asp511Thr mutation in McArdle disease with acute kidney injury caused by rhabdomyolysis, CEN CASE REPORTS, 8(3), 194-199, 201908
  113. High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate >= 60 mL/min/1.73 m(2): A cross-sectional study, PLOS ONE, 14(8), 20190801
  114. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients, RENAL FAILURE, 41(1), 770-777, 20190101
  115. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16(INK4a), KIDNEY INTERNATIONAL, 96(5), 1162-1175, 201911
  116. Vascular access management after percutaneous transluminal angioplasty using a calcium alginate sheet: a randomized controlled trial, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(9), 1592-1596, 201909
  117. Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(19), 201910
  118. Iliopsoas Abscess in Hemodialysis Patients With End-Stage Kidney Disease, THERAPEUTIC APHERESIS AND DIALYSIS, 23(6), 534-541, 201912
  119. Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma, CEN CASE REPORTS, 9(1), 48-54, 202002
  120. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli, CEN CASE REPORTS, 8(4), 266-270, 201911
  121. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells., J Biol Chem, 294(1), 101-115, 2019/1/4
  122. Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan, JOURNAL OF ARTIFICIAL ORGANS, 22(2), 146-153, 2019
  123. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study, HEMODIALYSIS INTERNATIONAL, 20(4), 580-588, 2016
  124. Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(6), 918-925, 2016
  125. Seasonal variation in hemodialysis initiation: A single-center retrospective analysis, PLOS ONE, 12(6), 2017
  126. A Case of Fibronectin Glomerulopathy Caused by Missense Mutations in the Fibronectin 1 Gene, KIDNEY INTERNATIONAL REPORTS, 2(5), 969-972, 2017
  127. Protective Effects of Japanese Soybean Paste (Miso) on Stroke in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP), AMERICAN JOURNAL OF HYPERTENSION, 31(1), 43-47, 2018
  128. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 78-84, 2018
  129. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (vol 22, pg 78, 2018), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 85-86, 2018
  130. A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-alpha and TGF-beta(1) pathways, SCIENTIFIC REPORTS, 7, 2017
  131. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report, BMC NEPHROLOGY, 19, 2018
  132. A case of immunotactoid glomerulopathy with false-negative IgG staining, BMC NEPHROLOGY, 19, 2018
  133. A consensus statement on health-care transition of patients with childhood-onset chronic kidney diseases: providing adequate medical care in adolescence and young adulthood, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 743-751, 2018
  134. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report, CLINICAL NEPHROLOGY, 90(3), 232-236, 2018
  135. Comparing the 12-month patency of low- versus high-pressure dilation in failing arteriovenous fistulae: A prospective multicenter trial (YOROI study), JOURNAL OF VASCULAR ACCESS, 19(5), 477-483, 2018
  136. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(5), 1167-1173, 2018
  137. TGF-beta 1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRA, SCIENTIFIC REPORTS, 8, 2018
  138. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis, STEM CELLS TRANSLATIONAL MEDICINE, 7(12), 893-905, 2018
  139. The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19(12), 2018
  140. Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(1), 217-223, 2019
  141. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients, INTERNATIONAL UROLOGY AND NEPHROLOGY, 51(6), 1043-1052, 2019
  142. Renal medullary tonicity regulates RNF183 expression in the collecting ducts via NFAT5, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(2), 436-442, 2019
  143. microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress, PLOS ONE, 14(6), 2019
  144. Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice, DIABETOLOGY & METABOLIC SYNDROME, 11, 2019
  145. High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate >= 60 mL/min/1.73 m(2): A cross-sectional study, PLOS ONE, 14(8), 2019
  146. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients, RENAL FAILURE, 41(1), 770-777, 2019
  147. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16(INK4a), KIDNEY INTERNATIONAL, 96(5), 1162-1175, 2019
  148. Vascular access management after percutaneous transluminal angioplasty using a calcium alginate sheet: a randomized controlled trial, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(9), 1592-1596, 2019
  149. Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(19), 2019
  150. ELEVATION OF SERUM BISPHENOL S (BPS) CONCENTRATIONS IN PATIENTS UNDERGOING HEMODIAYLSIS (HD) BY CHANGING DIALYZERS FROM POLYSULFONE TO POLYETHERSULFONE MEMBRANES, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 227-227, 2019
  151. THE IMPACT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ON SERUM LIPID PROFILE IN HEMODIALYSIS (HD) PATIENTS, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 293-293, 2019
  152. DOCOSAHEXAENOIC ACID ADMINISTRATION INCREASES EGFR THROUGH UPREGULATION OF NNOS EXPRESSION, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 2019
  153. LDL-CHOLESTEROL LEVEL IS ASSOCIATED WITH DOWNREGULATION OF KLOTHO EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 471-471, 2019
  154. WEEKLY AND MONTHLY ERYTHROPOIESIS STIMULATING AGENTS ARE REMOVED DURING HEMODIALYSIS SESSION, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 521-521, 2019
  155. Iliopsoas Abscess in Hemodialysis Patients With End-Stage Kidney Disease, THERAPEUTIC APHERESIS AND DIALYSIS, 23(6), 534-541, 2019
  156. Relationship of serum magnesium level with body composition and survival in hemodialysis patients, HEMODIALYSIS INTERNATIONAL, 24(1), 99-107, 2020
  157. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 24(5), 435-443, 2020
  158. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats, STEM CELL RESEARCH & THERAPY, 11(1), 130-130, 2020
  159. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells, JOURNAL OF BIOLOGICAL CHEMISTRY, 294(1), 101-115, 2019
  160. TELOMERIC G-TAIL LENGTH AS A GOOD PREDICTOR OF CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS, NEPHROLOGY, 19, 116-117, 2014
  161. A classic variant of Fabry disease in a family with the M296I late-onset variant, CEN CASE REPORTS, 10(1), 106-110, 202102
  162. Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 25(2), 110-119, 202102
  163. Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis, RENAL FAILURE, 43(1), 371-380, 20210101
  164. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis, STEM CELL RESEARCH & THERAPY, 12(1), 20210323
  165. Interferon-gamma enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis, SCIENTIFIC REPORTS, 11(1), 20210113
  166. Linagliptin Ameliorates MethylglyoxalInduced Peritoneal Fibrosis in Mice, PLOS ONE, 11(8), 2016
  167. Chronic kidney disease caused by maternally inherited diabetes and deafness: a case report, CEN CASE REPORTS, 10(2), 220-225, 202105
  168. Association and predictive value of geriatric nutritional risk index, body composition, or bone mineral density in haemodialysis patients, NEPHROLOGY, 26(4), 341-349, 202104
  169. Localization and Maintenance of Engrafted Mesenchymal Stem Cells Administered via Renal Artery in Kidneys with Ischemia-Reperfusion Injury, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(8), 202104
  170. Low-Vacuum Scanning Electron Microscopy to Assess Histopathological Resolution of Class V Lupus Nephritis: A Case Report, CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 11(1), 36-47, 2021
  171. Effectiveness of a treatment algorithm for hemodialysis-associated pruritus in terms of changes in medications, RENAL REPLACEMENT THERAPY, 7(1), 20210526
  172. Valproic acid attenuates renal fibrosis through the induction of autophagy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 21(5), 771-780, 2017
  173. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients, NEPHROLOGY, 22(12), 947-953, 2017
  174. Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS, 22(1), 31-39, 2018
  175. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients, INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 41(3), 135-143, 2018
  176. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, PLOS ONE, 13(5), 2018
  177. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis, PLOS ONE, 12(3), 2017
  178. High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 835-842, 2018
  179. Klotho as a Therapeutic Target during the Development of Renal Fibrosis, SCIENTIFIC ASPECTS OF DIALYSIS THERAPY, 189, 178-183, 2017
  180. Dec1 and CLOCK Regulate Na+/K+-ATPase 1 Subunit Expression and Blood Pressure, HYPERTENSION, 72(3), 746-754, 2018
  181. Na+-Cl- cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused rats, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 315(2), F300-F312, 2018
  182. Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction, PLOS ONE, 13(8), 2018
  183. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, NEPHROLOGY, 23(9), 837-845, 2018
  184. Eighteen-year follow-up cohort study on hepatitis B and C virus infections related long-term prognosis among hemodialysis patients in Hiroshima, Journal of Medical Virology, 20200624
  185. Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy, Intestinal Research, 202009
  186. A case report of adult-onset COQ8B nephropathy presenting focal segmental glomerulosclerosis with granular swollen podocytes, BMC Nephrology, 21(1), 376-376, 202008
  187. Different risk factors are associated with vascular access patency after construction and percutaneous transluminal angioplasty in patients starting hemodialysis, The Journal of Vascular Access, 22(5), 707-715, 202109
  188. Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis, STEM CELL RESEARCH & THERAPY, 12(1), 20210823
  189. Lower Geriatric Nutritional Risk Index (GNRI) Is Associated with Higher Risk of Fractures in Patients Undergoing Hemodialysis, NUTRIENTS, 13(8), 202108
  190. N-terminal pro brain natriuretic peptide predicts both all-cause and cardiovascular disease mortality in Japanese hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 25(10), 1142-1150, 202110
  191. The histopathological spectrum of kidney biopsies in patients with thymoma and myasthenia gravis: a report of 24 biopsies from a single institution, CLINICAL KIDNEY JOURNAL, 14(9), 2090-2100, 202109
  192. Klotho overexpression protects against renal aging along with suppression of transforming growth factor-beta 1 signaling pathways, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 321(6), F799-F811, 202112
  193. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys, PLOS ONE, 16(10), 2021

Invited Lecture, Oral Presentation, Poster Presentation

  1. Epidemiology of Medical Kidney Disease in the Southwestern United States, 1989-2018, Takahashi A, Miyauchi T, Kevin Ren KYM, Doi T, Masaki T, Yamashita M, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  2. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients, Ookubo A, Doi T, Nishizawa Y, Shigemoto K, Mizuiri S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  3. The Effect of Predilution Online Hemodiafiltration on Body Composition, Nutritional Status, and Mortality, Mizuiri S, Nishizawa Y, Okubo A, Doi T, Yamashita K, Shigemoto K, Usui K, Michiko Arita, Naito T, Doi S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  4. Coronary Artery Calcification Is a Risk Factor for Intradialytic Hypotension in Hemodialysis Patients, Mizuiri S, Nishizawa Y, Doi T, Yamashita K, Shigemoto K, Usui K, Arita M, Naito T, Doi S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  5. Identification of Factors Affecting Changes in the Agatston Coronary Artery Calcification Score in Maintenance Hemodialysis Patients, Morii K, Doi T, Nishizawa Y, Shigemoto K, Mizuiri S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  6. Inhibition of H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, Ryo Tamura, Shigehiro Doi, Toshinori Ueno, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  7. TGF-b1 promotes fibrotic gene expression through induction of histone variant H3.3 and histone chaperone HIRA, Toshihiro Shindo, Shigehiro Doi, Kensuke Sasaki, Ayumu Nakashima, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  8. MicroRNA-200c is involved in Klotho reduction by oxidative stress in human tubular cells, Kenichi Morii, Satoshi Yamasaki, Shigehiro Doi, Kensuke Sasaki, Toshinori Ueno, Ayumu Nakashima, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  9. Prognostic Factors in sepsis patients who have undergone direct hemoperfusion with polymyxin b-immobilized fibers, Aiko Okubo, Ayumu Nakashima, Shigehiro Doi, Toshihiro Ueno, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  10. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental renal fibrosis by their strong immunosuppressive effects, Ken Yoshida, Ayumu Nakashima, Shigehiro Doi, Toshinori Ueno, Yukio Kato, Yukihito Higashi, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  11. Inhibition of H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, Ryo Tamura, Shigehiro Doi, Toshinori Ueno, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  12. TGF-b1 promotes fibrotic gene expression through induction of histone variant H3.3 and histone chaperone HIRA, Toshihiro Shindo, Shigehiro Doi, Kensuke Sasaki, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  13. MicroRNA-200c is involved in Klotho reduction by oxidative stress in human tubular cells, Kenichi Morii, Satoshi Yamasaki, Shigehiro Doi, Kensuke Sasaki, Toshinori Ueno, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, Japanese
  14. Prognostic Factors in sepsis patients who have undergone direct hemoperfusion with polymyxin b-immobilized fibers, Aiko Okubo, Ayumu Nakashima, Shigehiro Doi, Toshihiro Ueno, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  15. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental renal fibrosis by their strong immunosuppressive effects, Ken Yoshida, Ayumu Nakashima, Shigehiro Doi, Toshinori Ueno, Yukio Kato, Yukihito Higashi, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  16. Inhibitory Effect the Chromatin Histone H3-Lysine 4 Methyltransferase(SET7/9)on the Tubulointerstitial Fibrosis, Kensuke Sasaki, Ayumu Nakashima, Shigehiro Doi, Takao Masaki, American Society of Nephrology 2014, 2014/11/11, Without Invitation, English
  17. Mizoribine Suppressed Pyroptosis and Ameliorated Renal Inflammation in Aldosterone-Salt Treated Rats, Toshiki Doi, Shigehiro Doi, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2013, 2013/11/06, Without Invitation, English
  18. High Glucose Promotes TGF-β1 Productiono by Inducing FOS Expression in Human Peritoneal Mesothelial Cells, Shigehiro Doi, Keiko Kokoroishi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology 2013, 2013/11/06, Without Invitation, English
  19. Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, Toshinori Ueno, Shigehiro Doi, Toru Kawai, Takao Masaki, WCN 2014 Satellite Symposium Kidney and Lipids, 2013/06/06, Without Invitation, English, fukuoka
  20. Comparison of Survival rate between Hemodialysis and Peritoneal dialysis patients: A prospective cohort study with Propensity score matching, Mami Miyazaki, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  21. Klotho Deficiency Intensifies Hypoxia-Induced Expression of INF-a/b Through Upregulation of Rig-I, Asako Urabe, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  22. A Combination of Contrast Media and Radiation Increases DNA Damage and Delays DNA Damage Repair in Mouse Kidneys, Shu Fujino, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  23. Combined Value of Geriatric Nutritional Risk Index, Body Composition, and Bone Mineral Density for Predicting Mortality of Hemodialysis Patients, Sonoo Mizuiri, Nishizawa Yoshiko, Kazuomi Yamashita, Shigehiro Doi, Shigemoto Kennichiro, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  24. Association Among Iron, Coronary Artery Calcification, and Mortality in Hemodialysis Patients, Sonoo Mizuiri, Nishizawa Yoshiko, Kazuomi Yamashita, Usui Kohji, Shigehiro Doi, Shigemoto Kennichiro, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  25. Inhibition of Mineralocorticoid Receptor Ameliorates Salt-Sensitive Hypertension After Ischemic-Reperfusion Injury in Rats, Takumi Matsumoto, Shigehiro Doi, Ayumu Nakashima, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English

External Funds

Acceptance Results of Competitive Funds

  1. KAKENHI, 2014, 2016
  2. KAKENHI, 2013, 2015
  3. KANENHI, 2016, 2018
  4. KAKENHI, 2017, 2020
  5. KAKEN, 2016, 2018
  6. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2017, 2019
  7. KAKENHI, 2019, 2022
  8. KAKENHI, 2016, 2018

Social Activities

Organizing Academic Conferences, etc.

  1. The 32th Annual Meeting of the Chugoku Society for Renal Failure, 2022/12, 2022/12
  2. The 27th Annual Meeting of Japanese Society for Hemodiafiltration, 2021/10, 2021/10